Volume 1, Number 3—July 1995
Simultaneous Infection of Ixodes ricinus Nymphs by Two Borrelia burgdorferi Sensu Lato Species: Possible Implications for Clinical Manifestations
Data from European studies indicate that in humans, particular Borrelia burgdorferi genospecies may be associated with specific clinical manifestations of Lyme disease. Infections by B. burgdorferi sensu stricto tend to lead to arthritic symptoms, whereas infections by B. garinii appear to cause neurologic complications. Late cutaneous manifestations (acrodermatitis) appear to be associated with B. afzelii (1). Mixed clinical manifestations have also been described (2). Recently it has been demonstrated, by using polymerase chain reaction (PCR), that DNA from more than one of the three Borrelia species associated with Lyme disease in Europe was present in the biological fluids of Lyme disease patients (3). These data raise questions concerning the relative growth of the Borrelia species after a bite by a dually infected tick, the clinical significance of human infection caused by more than one species of Borrelia, and the origin of these multiple infections. This last point evokes the following question: do they result from successive bites by two infected ticks or from a single bite by a tick infected by more than one species?
To investigate whether ticks are infected by different species of the B. burgdorferi complex at the same time, we carried out a survey of the vector Ixodes ricinus during the spring of 1994, in Rambouillet Forest near Paris. A total of 249 unfed nymphs, collected from vegetation, were analyzed by PCR. The ticks were then crushed in phosphate-buffered saline, solubilized in 0.5% Tween 20, and boiled for 10 min. The resulting lysate was used as a template for the amplification reactions by either the universal ospA-based primers SL or the three pairs of genospecific-based primers (3). These last primers distinguish the three Lyme disease-associated B. burgdorferi sensu lato species, i.e., B. burgdorferi sensu stricto, B. garinii, and B. afzelii. In some cases, amplified DNA products were digested with specific restriction enzymes to confirm the typing of the Borrelia strain.
Thirty of the 249 nymphs were positive for B. burgdorferi when SL universal primers were used. Further testing of 5 of 30 nymphs by PCR, using genospecific primer sets and restriction analysis, did not confirm the preliminary results with the universal primers. This may have been due either to the genotypic variability of B. burgdorferi sensu lato or to the existence of other distinct subgroups or genomic species included in B. burgdorferi sensu lato, as other data appear to indicate (4). Of the 25 other nymphs, 22 were analyzed by both restriction analyses and the specific primers, and three by restriction analysis alone. (The available tick material was not sufficient to perform PCR with genospecific primers.) Nineteen nymphs were infected by a single species of Borrelia (four by B. garinii, 15 by B. afzelii), and six were infected by more than one (two by both B. burgdorferi sensu stricto and B. garinii, three by B. garinii and B. afzelii, one by B. burgdorferi sensu stricto and B. afzelii).
From these results, it appears that when nymphs are infected with one species, B. afzelii is the most prevalent. This species may actually be prevalent in this study area or may have a greater tropism for dermal tissue and/or for the peripheral circulatory system of the vertebrate than the other two species. In infected nymphs, the simultaneous presence of more than one genospecies in unfed nymphs of I. ricinus was not exceptional (24%), and all combinations of two species were observed. The association of three genospecies has not yet been detected. Simultaneous infections in unfed nymphs could have different explanations. The first is a larval meal on a host infected by more than one species. Recently, Apodemus speciosus (field mice) infected by two different species have been found (5). A second possibility is successive infectious interrupted larval meals. A third possibility is an infectious larval meal by a previously transovarially infected larva. The fourth possibility is a mixed infection acquired transovarially.
This work was supported by grants from the Recherche & Partage Association, the Gould Foundation, and the Conseil du Departement du Val d'Oise. E. Godfroid, B. Hoyois, and A. Bollen, were supported by a grant from the Walloon Region of Belgium (Convention UIB, Region Wallonne No. 2267).
- Assous MV, Postic D, Paul G, Nevot P, Baranton G. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strain used as antigens. Eur J Clin Infect Dis. 1993;12:261–8.
- Wienecke R, Neubert U, Volkenandt M. Cross-immunity among types of Borrelia burgdorferi. Lancet. 1993;341:830–1.
- Demaerschalck I, Ben Messaoud A, De Kesel M, Hoyois B, Lobet Y, Hoet P, Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients. J Clin Microbiol. 1995;33:602–8.
- Nohlmans LMKE, De Boer R, Van Den Boggard AEJM, Van Boven CPA. Genotypic and phenotypic analysis of Borrelia burgdorferi isolates from the Netherlands. J Clin Microbiol. 1995;33:119–25.
- Nakao M, Miyamoto K. Mixed infection of different Borrelia species among Apodemus speciosus mice in Hokkaido, Japan. J Clin Microbiol. 1995;33:490–2.
Suggested citation: Pichon B, Godfroid E, Hoyois B, Bollen A, Rodhain R, and Pérez-Eid C. Simultaneous Infection of Ixodes ricinus Nymphs by Two Borrelia burgdorferi Sensu Lato Species: Possible Implications for Clinical Manifestations. Emerg Infect Dis [serial on the Internet]. 1995, Sep [date cited]. Available from http://wwwnc.cdc.gov/eid/article/1/3/95-0304
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 20, 2010
- Page last updated: December 20, 2010
- Page last reviewed: December 20, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)